Caladrius Biosciences, Inc. carries a market capitalization of 3.35M, placing it among publicly traded companies globally.
| Market Cap | 3.35M |
| Enterprise Value | N/A |
Caladrius Biosciences, Inc.'s stock has declined approximately -96.25965% over the past 52 weeks.
| Beta (5Y) | N/A |
| 52-Week Price Change | -96.25965% |
| 50-Day Moving Average | N/A |
| 200-Day Moving Average | N/A |
| Average Volume (20 Days) | N/A |
Caladrius Biosciences, Inc.'s most recent stock split took place on September 15, 2022 with a 15:1 split ratio.
| Last Split Date | 9/15/2022 |
| Split Ratio | 15:1 |